BioWorld Asia

Jan. 9, 2002

View Archived Issues

PPL Clones Knockout Pigs, Says Dolly’s Arthritis Not A Setback

New Heart Drugs Could Be Hiding In A Glass Of Vin Rouge

NeuTec Raising 10M To Fund Programs Targeting Infections

Budget Cuts Sidetrack Plan For Israeli Biotech Institute

Antisoma, Abbott Restructure Deal Regarding Cancer Drug

Novartis Enlists Optimata To Analyze New Drug Candidates

Strakan Raises Another £15M, Gains UK Approval For Zindaclin

ExonHit Partners With IDEC To Develop Antibody Therapeutics

PARIS - ExonHit Therapeutics SA and IDEC Pharmaceuticals Corp. signed a collaboration and research agreement aimed at discovering new antigen targets for antibody therapy, with a particular focus on prostate carcinoma. Read More

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 25, 2026.

Have brain-computer interfaces finally arrived?

BioWorld

More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 23, 2026

Brain-computer interfaces are here but long road ahead

BioWorld

The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...

2026 marks critical turning point for BCI technology

BioWorld

Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...